BioCentury
ARTICLE | Company News

NewBiotics, Theratechnologies deal

July 12, 2004 7:00 AM UTC

TH's majority-owned subsidiary, Celmed BioSciences Inc. (Montreal, Quebec), completed its previously announced acquisition of cancer company NewBiotics (see BioCentury, June 14). NewBiotics sharehold...